Skip to main content

Table 1 Characteristics of included studies according to evaluated cost

From: The costs associated with stroke care continuum: a systematic review

 

HEALTH CARE SYSTEM COST

COST Nonrelated with Health CARE SYSTEM Cost

PRODUCTIVITY COSTS

Author, year, country

PP

ACUTE STROKE

POST ICTUS

SOCIAL CARE

PATIENTS AND CAREGIVERS COST

MORBIDITY LOSSES

MORTALITY LOSSES

HTA

AF

Wodchis WP, 2011 (Canada) [30]

 

X

      

Cotte,2016

(France) [31]

 

X

      

López-López

2017, (UK) [32]

 

X

      

Giner-Soriano, 2020 (Spain) [33]

 

X

      

Zhang, 2017,

(EEUU)[34]

X

       

Gheorghe, 2018 (UK) [35]

X

       

Kostova, 2020 (EEUU) [36]

X

       

Salvatore, 2021 (Italy) [29]

X

X

      

Shireman TI,2017 (EEUU) [37]

  

X

     

Zhang H, 2019

(China), [38]

  

X

X

    

Abdo RR, 2018

(Leban)[20]

  

X

     

Reimer AP, 2019 [39]

  

X

     

De Andres 2014 (Spain) [40]

  

X

X

    

Van Meijeren-Pont W, 2016 [41]

  

X

X

    

Oliva-Moreno, 2013 (Spain) [42]

     

X

  

Skolarus, 2016 (EEUU) [43]

     

X

  

Joo H, 2017

(EEUU) [3]

     

X

  

Alvarez-Sabin, 2013, (Spain) [44]

  

X

X

  

X

 

Van Eeden, 2015 (Netherlands) [45]

   

X

X

X

X

X

Xu. 2018

(UK) [46],

  

X

X

X

X

X

X

Benjamin. 2019

(EEUU)[4]

  

X

X

  

X

X

Luengo-Fernandez, 2020 (UK) [2],

  

X

X

X

X

X

X

Patel A, 2020(UK) [47]

  

X

X

X

X

X

X

Rochmah TN., 2021 (Indonesia)

[48]

  

X

X

X

X

X

X

Stefan Strilciuc, 2021 Romania [49]

  

X

X

X

X

X

X

  1. *PP Primary Prevention, HTA Arterial Hypertension, AF Atrial Fibrillation